January 3, 2017

IO Biotech closes Series A Round including new investor Sunstone Capital to the investor syndicate

IO Biotech today announced successful closure of the €8.5 million second tranche series A investment round. Participants were existing investors Lundbeckfonden and Novo Seeds plus new investor Sunstone Capital.

Read IO Biotech’s news release